Sirtuin 3: Emerging therapeutic target for cardiovascular diseases

Free Radic Biol Med. 2022 Feb 20:180:63-74. doi: 10.1016/j.freeradbiomed.2022.01.005. Epub 2022 Jan 11.

Abstract

Acetylation is one of the most important methods of modification that lead to a change in the function of proteins. In humans, metabolic enzymes commonly undergo acetylation, which regulates the activities of metabolic enzymes and metabolic pathways. Sirtuin 3 (SIRT3) is a prominent deacetylase that participates in mitochondrial metabolism, redox balance, and mitochondrial dynamics by regulating mitochondrial protein acetylation, thereby protecting mitochondria from damage. Normal mitochondrial function is essential for maintaining the metabolism and function of the heart. Therefore, mitochondrial dysfunction caused by SIRT3 consumption and defects leads to the development of a variety of cardiovascular diseases. A comprehensive understanding of the role of SIRT3 in cardiovascular disease is critical for developing new therapeutic strategies. Herein, we summarize the function of SIRT3 in mitochondria, the complex mechanisms mediating cardiovascular diseases, and the potential value of SIRT3 small-molecule agonists in future clinical treatments.

Keywords: Acetylation; Cardiovascular diseases; Mitochondria; Sirtuin 3.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acetylation
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / metabolism
  • Humans
  • Mitochondria / metabolism
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism
  • Sirtuin 3* / genetics
  • Sirtuin 3* / metabolism

Substances

  • Mitochondrial Proteins
  • Sirtuin 3